Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
Open Access
- 18 June 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (2), 2001754
- https://doi.org/10.1183/13993003.01754-2020
Abstract
More than half of patients with Covid-19 pneumonia exhibit abnormal lung function 30 days after symptoms onset, without clear relationship with pneumonia extent on chest-CT. This pleads for systematic and long-term follow-up of patients with Covid.Keywords
This publication has 12 references indexed in Scilit:
- Temporal Changes of CT Findings in 90 Patients with COVID-19 Pneumonia: A Longitudinal StudyRadiology, 2020
- COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment optionsCardiovascular Research, 2020
- Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infectionIntensive Care Medicine, 2020
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across TissuesCell, 2020
- COVID-19 patients and the radiology department – advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI)European Radiology, 2020
- High-resolution Chest CT Features and Clinical Characteristics of Patients Infected with COVID-19 in Jiangsu, ChinaInternational Journal of Infectious Diseases, 2020
- Accumulation and immunotoxicity of microplastics in the estuarine worm Hediste diversicolor in environmentally relevant conditions of exposureEnvironmental Science and Pollution Research, 2020
- Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT—correlation with microvascular densityEuropean Radiology, 2019
- Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for CaucasiansEuropean Respiratory Journal, 2017
- The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosisAntiviral Research, 2017